Parallel Trade Conference

5 February - 6 February, 2019

hsidhu@sim-online.co.uk

+44 (0)20 7827 6000

http://go.evvnt.com/282724-0?pid=5394

Holiday Inn London - Kensington Forum, United Kingdom

Organized By:

SMi Group

+44 (0)20 7827 6000

events@smi-online.co.uk

https://www.smi-online.co.uk/

King's Rd, Haslemere GU27 2QH, United Kingdom

About Parallel Trade Conference

SMi presents its 13th annual Parallel Trade conference, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The 2019 event will hold a particular place of significance due to Brexit and the UK officially leaving the EU on the 29th of March 2019. As such, the UK will no longer be part of the EU free market; hence, having a significant impact on parallel trade.

Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2019. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.

Speakers

Speaker

More...

Visitors Profile

ABACUS MEDICINE A/S; Abbvie Deutschland GmbH & Co. KG; ABPI; Aeterna Zentaris GmbH; Amgen ; APM Health Europe; Apotek Hjärtat AB; Arnold & Porter Kaye Scholer LLP; Arnold and Porter Kaye Scholer LLP; Astellas Pharma Ltd; ASTRAZENECA; AstraZeneca Czech Republic; Bristol Myers Squibb; Cartermatic Trading Enterprise; Chiesi Farmaceutici SpA; Clinical Insights; Clinigen Group; Daiichi Sankyo Europe GmbH; Diamond BioPharm Ltd; Durbin Plc; Ema; Europe Economics; European Alliance for Access to Safe Medicines; European Association of Euro-Pharmaceutical Companies ; Ferring Pharmaceuticals; Ferring Pharmaceuticals Ltd; Gilead Sciences Ltd; Grunenthal GmbH; H.Lundbeck; Idea Medica Limited; IMS Health GmbH & Co. OHG; IQVIA; Janssen Pharmaceutica NV; Johnson and Johnson ; Kantar Health; Kantar Health GmbH; LEO Pharma; medac GmbH; MHRA; MPA Business Services Ltd; Napp Laboratories; NOVARTIS PHARMA AG; Novartis Pharmaceuticals UK Ltd; NOVARTIS TURKEY; Novo Nordisk Pharma AG; Nupharm Laboratories Ltd; Omnia Läkemedel; Pharm-in, spol . S.R.O; Phoenix Healthcare Distribution Limited; QuintilesIMS; Ratiopharm GmbH; Research Health; Shire Pharmaceuticals Limited; Smith & Nephew; Sobi; Sunovion Pharmaceuticals Europe Ltd.; Swedish Orphan Biovitrum AB (publ); Takeda Pharmaceuticals International AG; Teva UK Limited; Tioluxe Pte Ltd; Vertex Pharmaceuticals (Europe) Ltd; Vifor Pharma Ltd.;

Event Partners

More...